An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene

Byoung Y Ryu1, Marguerite V Evans-Galea, John T Gray

  • 1Department of Hematology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.

Blood
|November 10, 2007
PubMed

Insights

Gene therapy safety concerns, particularly LMO2 proto-oncogene activation in X-linked severe combined immunodeficiency (X-SCID) trials, were addressed. Researchers developed a system to compare vector safety, reducing proto-oncogene activation risks.

Area of Science:

  • Gene therapy
  • Oncology
  • Immunology

Background:

  • Clinical trials using oncoretroviral vectors for X-linked severe combined immunodeficiency (X-SCID) faced safety issues due to LMO2 proto-oncogene activation.
  • This activation poses a significant risk for leukemogenesis in patients.

Purpose of the Study:

  • To develop and validate a system for comparing the safety profiles of different gene therapy vector cassettes.
  • To assess the potential for proto-oncogene activation by various regulatory elements within gene therapy vectors.

Main Methods:

  • Adeno-associated virus (AAV) vector used for targeted insertion of a gamma-retroviral LTR-GFP cassette into the LMO2 gene in a human T-cell line.
  • Cre-mediated cassette exchange employed to replace the LTR-GFP cassette with insulator-flanked or globin gene regulatory cassettes.
  • Comparison of LMO2 expression levels after insertion of different vector designs, including gamma-retroviral and self-inactivating lentiviral vectors.

Main Results:

  • Insertion of the LTR-GFP cassette into the LMO2 gene's first intron strongly activated LMO2 expression.
  • Replacing the cassette with insulator-flanked elements reduced LMO2 expression significantly.
  • A self-inactivating lentiviral vector with insulator elements did not activate LMO2, unlike a gamma-retroviral vector.

Conclusions:

  • The developed system effectively compares vector cassette safety regarding proto-oncogene activation.
  • Vector design, particularly the use of insulators and self-inactivating elements, is crucial for mitigating risks like LMO2 activation in gene therapy.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...